DIPG-24. COMBINED EPIGENETIC THERAPY WITH FACT AND BET INHIBITORS REMODELS CHROMATIN AND DISRUPTS ONCOGENIC TRANSCRIPTION IN DIFFUSE MIDLINE GLIOMA

Authors: Holly Holliday, Aaminah Khan, Nisitha Jayatilleke, Chelsea Mayoh, Samuel E Ross, Xinyi Guo, Yolanda Colino Sanguino, Anjana Gopalakrishnan, Anahid Ehteda, Maria Tsoli, David S Ziegler

Published: 2024-06-18

DOI: 10.1093/neuonc/noae064.077

Source: Full article


Abstract

Abstract